1.Meyle J., Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000. 2015. 69:7–17.
2.Gemmell E., Marshall RI., Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000. 1997. 14:112–43.
3.Kumar M., Mishra L., Mohanty R., Nayak R. Diabetes and gum disease: the diabolic duo. Diabetes Metab Syndr. 2014. 8:255–8.
4.Mealey BL., Oates TW; American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol. 2006. 77:1289–303.
5.Seppälä B., Ainamo J. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-de-pendent diabetes mellitus. J Clin Periodontol. 1994. 21:161–5.
6.Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993. 16:329–34.
7.Taylor GW., Burt BA., Becker MP., Genco RJ., Shlossman M., Knowler WC, et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol. 1998. 69:76–83.
8.Collison KS., Parhar RS., Saleh SS., Meyer BF., Kwaasi AA., Hammami MM, et al. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol. 2002. 71:433–44.
9.Takeda M., Ojima M., Yoshioka H., Inaba H., Kogo M., Shizukuishi S, et al. Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients. J Periodontol. 2006. 77:15–20.
10.Lalla E., Lamster IB., Stern DM., Schmidt AM. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol. 2001. 6:113–8.
11.Chang PC., Chien LY., Yeo JF., Wang YP., Chung MC., Chong LY, et al. Progression of periodontal destruction and the roles of advanced glycation end products in exper-imental diabetes. J Periodontol. 2013. 84:379–88.
12.Janket SJ., Wightman A., Baird AE., Van Dyke TE., Jones JA. Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res. 2005. 84:1154–9.
13.Noack B., Genco RJ., Trevisan M., Grossi S., Zambon JJ., De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001. 72:1221–7.
14.Nishimura F., Iwamoto Y., Mineshiba J., Shimizu A., Soga Y., Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relation-ship. J Periodontol. 2003. 74:97–102.
15.Sanz M., Ceriello A., Buysschaert M., Chapple I., Demmer RT., Graziani F, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018. 137:231–41.
16.Sharma P., Dietrich T., Ferro CJ., Cockwell P., Chapple IL. Association between periodontitis and mortality in stages 3-5 chronic kidney disease: NHANES III and linked mortality study. J Clin Periodontol. 2016. 43:104–13.
17.Tonetti MS., Van Dyke TE; working group 1 of the joint EFP/AAP workshop*. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAPWorkshop on Periodontitis and Systemic Diseases. J Periodontol. 2013. 84(Suppl 4S):S24–9.
18.Madianos PN., Koromantzos PA. An update of the evidence on the potential impact of periodontal therapy on diabetes outcomes. J Clin Periodontol. 2018. 45:188–95.